Liberate Bio
United States · $31.0M raised
- Employees
- 11–50
- Business Model
- B2B
- Website
- liberatebio.com
- Total Funding
- $31.0M
- Last Round
- $31.0M SeedOct 2025
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.
About
Genetic medicines platform enabling in vivo reprogramming of disease-driving cells to cure disease.
Summary
Liberate Bio is a Biotech company based in United States. It has raised $31.0M in total across 1 round, most recently a $31.0M Seed round in Oct 2025. Investors include Khosla Ventures.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Oct 2025
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/liberate-bio"><img src="https://indexed.vc/api/badge/company/liberate-bio" alt="Liberate Bio on Indexed.vc" width="260" height="76" /></a>